REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Proquident S.A. (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Proquident S.A. Profile Updated: March 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Proquident S.A. is a company in Colombia, with a head office in Guarne. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. The company was established on July 19, 2019. It currently has a total number of 306 (2023) employees. From the latest financial highlights, Proquident S.A. reported a net sales revenue increase of 6.52% in 2022. Over the same period, its total assets decreased by 3.29%. Proquident S.A.’s net profit margin decreased by 3.91% in 2022.

Headquarters
Autopista Medellin Bogota Entre Retorno 11 y 12 Entrando 1.5Km Via Batallon Juan del Corral Vrd Garrido
Guarne; Antioquia;

Contact Details: Purchase the Proquident S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Proquident S.A. report to view the information.
Outstanding Shares:
Purchase the Proquident S.A. report to view the information.
Incorporation Date:
July 19, 2019
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Treasurer
Company Performance
Financial values in the chart are available after Proquident S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
6.52%▲
Total operating revenue
7.65%▲
Operating profit (EBIT)
-59.26%▼
EBITDA
-36.49%▼
Net Profit (Loss) for the Period
-82.28%▼
Total assets
-3.29%▼
Total equity
-5.03%▼
Operating Profit Margin (ROS)
-4.16%▼
Net Profit Margin
-3.91%▼
Return on Equity (ROE)
-12.66%▼
Debt to Equity Ratio
18.53%▲
Quick Ratio
-0.06%▼
Cash Ratio
-0.09%▼

Similar companies

Droguerias y Farmacias Cruz Verde S.A.S
 
Tecnoquimicas S.A.
Bayer S A
 
Procaps S.A.
Novartis de Colombia S A
 
Pfizer S A S
Laboratorios Incobra S.A.
 
Lafrancol Internacional S.A.S.
Manufacturera Mundial Farmaceutica S A
 
Inversiones Leal y Oxigenos Sas
Farmalogica S A
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo